Hagit Binder
Directeur des opérations chez NEUROSENSE THERAPEUTICS LTD.
Fortune : 27 720 $ au 30/04/2024
Profil
Hagit Binder is currently the Chief Operating Officer at Neurosense Therapeutics Ltd.
Prior to this, she worked as the VP-Projects & Marketing at Nextar Chempharma Solutions Ltd.
from 2018 to 2022.
Ms. Binder completed her undergraduate, graduate, and MBA degrees at Bar-Ilan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 22 000 ( 0,13% ) | 27 720 $ | 30/04/2024 |
Postes actifs de Hagit Binder
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Directeur des opérations | - |
Anciens postes connus de Hagit Binder
| Sociétés | Poste | Fin |
|---|---|---|
Nextar Chempharma Solutions Ltd.
 Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Sales & Marketing | 01/01/2022 |
Formation de Hagit Binder
| Bar-Ilan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Health Technology |
